Gilead
Sciences Inc said on Sunday it was temporarily putting new
emergency access to its experimental coronavirus drug remdesivir on
hold due to overwhelming demand and that it wanted most people
receiving the drug to participate in a clinical trial to prove if
it is safe and effective. The spread of the virus in Europe and the
United States has “flooded an emergency treatment access system
that was set up for very limited access to investigational
medicines and never intended for use in response to a pandemic,” it
said. Gilead said it would keep processing previously approved
requests.
Gilead puts emergency access to experimental coronavirus drug on hold amid surging demand
Prepare Now Before its too Late
Discover where products are available & compare prices
